Multistate Salmonella outbreak linked to pistachio cream: CDC
A multistate Salmonella outbreak has been linked to Emek-brand pistachio cream, according to the Centers for Disease Control and Prevention (CDC).
'CDC and public health officials in two states are investigating a multistate outbreak of Salmonella infections linked to pistachio cream,' the CDC said on its website. 'Do not eat, sell, or serve Emek-brand pistachio cream with a use by date of October 19, 2026.'
According to the CDC, there have been 4 cases in the outbreak in Minnesota and New Jersey, with one hospitalization.
The CDC's website said the pistachio cream might 'be packaged in a 5-kilogram white tub.'
In late May, the Food and Drug Administration (FDA) upgraded a recall on tomatoes sold by Williams Farms Repack, also due to contamination with salmonella.
In April, the United States Department of Agriculture (USDA) said it was withdrawing a proposed rule from former President Biden's recent term that would restrict salmonella levels in raw poultry.
The rule would have made corporations test contamination levels in chicken and poultry infected with strains tied to the meat-borne disease.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
3 hours ago
- Los Angeles Times
Dismissed members of CDC vaccine committee call Kennedy's actions ‘destabilizing'
NEW YORK — All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying 'destabilizing decisions' made by U.S. Health Secretary Robert F. Kennedy Jr. that could lead to more preventable disease spread. Kennedy last week announced he would 'retire' the entire panel that guides U.S. vaccine policy. He also quietly removed Dr. Melinda Wharton — the veteran Centers for Disease Control and Prevention official who coordinated the committee's meetings. Two days later, he named eight new people to the influential panel. The list included a scientist who criticized COVID-19 vaccines, a leading critic of pandemic-era lockdowns and someone who worked with a group widely considered to be a leading source of vaccine misinformation. 'We are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of U.S. immunization policy, impact people's access to lifesaving vaccines, and ultimately put U.S. families at risk of dangerous and preventable illnesses,' the 17 panelists wrote in the Journal of the American Medical Assn. The new committee is scheduled to meet next week. The agenda for that meeting has not yet been posted, but a recent federal notice said votes are expected on vaccinations against flu, COVID-19, HPV, RSV and meningococcal bacteria. In addition to Wharton's removal, CDC immunization staff have been cut and agency experts who gather or present data to committee members have resigned. One, Dr. Lakshmi Panagiotakopoulos, resigned after 12 years at CDC, disclosing her decision early this month in a note to members of a COVID-19 vaccines work group. Her decision came after Kennedy decided — without consulting the vaccine advisers — to pull back COVID-19 vaccination recommendations for healthy children and pregnant women. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in a message viewed by the Associated Press. Those CDC personnel losses will make it hard for a group of new outside advisers to quickly come up to speed and make fact-based decisions about which vaccines to recommend to the public, the former committee members said. 'The termination of all members and its leadership in a single action undermines the committee's capacity to operate effectively and efficiently, aside from raising questions about competence,' they wrote. A spokesperson for the U.S. Department of Health and Human Services did not respond to the JAMA commentary, but instead pointed to Kennedy's previous comments on the committee. Kennedy, a leading voice in the anti-vaccine movement before becoming the U.S. government's top health official, has accused the committee of being too closely aligned with vaccine manufacturers and of rubber-stamping vaccines. The Advisory Committee on Immunization Practices, created in 1964, makes recommendations to the CDC director on how vaccines that have been approved by the Food and Drug Administration should be used. CDC directors almost always approve those recommendations, which are widely heeded by doctors and guide vaccination programs. ACIP policies require members to state past collaborations with vaccine companies and to recuse themselves from votes in which they had a conflict of interest, but Kennedy has dismissed those safeguards as weak. Stobbe writes for the Associated Press.
New York Times
4 hours ago
- New York Times
E.P.A. Plans to Reconsider a Ban on Cancer-Causing Asbestos
The Trump administration plans to reconsider a ban on the last type of asbestos still used in the United States, according to a court filing on Monday. The move, which could halt enforcement of the ban for several years during the reconsideration, is a major blow to a decades-long battle by health advocates to prohibit the carcinogenic mineral in all its forms. Known as 'white' asbestos, chrysotile asbestos is banned in more than 50 countries for its link to lung cancer and mesothelioma, a cancer that forms in the lining of internal organs. White asbestos, however, has been imported for use in the United States for roofing materials, textiles and cement as well as gaskets, clutches, brake pads and other automotive parts. It is also used in chlorine manufacturing. Last year the Environmental Protection Agency, under President Joseph R. Biden, adopted a ban on the use, manufacture and import of chrysotile asbestos. It was the first legal constraint on a deadly substance since 2016, when Congress updated and strengthened the 1976 Toxic Substances Control Act by requiring testing and regulation of thousands of chemicals used in everyday products. The measure would have still allowed some manufacturers up to 12 years to phase out its use, a provision that followed lobbying efforts by trade groups like the American Chemistry Council. Now, the Trump administration plans to delay the ban and reconsider the rule. That process is expected to take about 30 months, the E.P.A. said in a filing with the Fifth Circuit Court of Appeals, which has been reviewing an industry challenge to the rule. Want all of The Times? Subscribe.
CBS News
4 hours ago
- CBS News
CDC official overseeing COVID hospitalization data resigns after RFK Jr.'s vaccine orders
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and Human Services Secretary Robert F. Kennedy Jr.'s orders to change the agency's vaccine recommendations and the committee that makes them. Dr. Fiona Havers' last day at the CDC was Monday, according to an announcement sent by an agency official to her branch within the agency's Coronavirus and Other Respiratory Viruses Division. They received the notice shortly after Reuters first reported on the resignation. "I no longer have confidence that these data will be used objectively or evaluated with appropriate scientific rigor to make evidence-based vaccine policy decisions," Havers wrote in an email sent to colleagues before the announcement. An infectious disease researcher who has worked with Havers, and received her email voicing concerns with how the data would be used, described the resignation as the latest in the "dismantling" of the agency's expertise. "It's a big loss to the CDC," the researcher, who spoke on the condition of anonymity, told CBS News. CBS News sent a request for comment to the CDC about the concerns that Havers expressed, but did not hear back from the agency's spokesperson. Instead, a spokesperson for the Department of Health and Human Services responded. "Under Secretary Kennedy's leadership, HHS is committed to following the gold standard of scientific integrity. Vaccine policy decisions will be based on objective data, transparent analysis, and evidence – not conflicts of interest or industry influence," Emily Hilliard, the department spokesperson, said in an email. Havers had led the CDC's Respiratory Virus Hospitalization Surveillance Network, or RESP-NET, that collects and studies trends in hospitalizations from COVID-19, RSV and influenza. Her presentations of RESP-NET's findings have figured prominently into past meetings of the agency's Advisory Committee of Immunization Practices as they weighed updates to the CDC's vaccine recommendations. "Of all the work we have accomplished, I am most proud of how COVID-NET and RSV-NET hospitalization data, presented at nearly every public ACIP meeting since 2020, have been critical drivers of COVID-19 and RSV vaccine policy in recent years," Havers wrote in her email. The CDC's vaccine recommendations are closely watched by doctors and health authorities because they are tied to federal policies enabling access to vaccines, including liability protections and requirements for insurance coverage. Usually, the ACIP deliberates and votes on updated recommendations, which are later adopted by the CDC director. In an unprecedented move this year, Kennedy bypassed the process to order his own changes. In late May, Kennedy first ordered narrowing the guidance to exclude children and pregnant women without other underlying health conditions, sidestepping an ACIP process that had been already underway to discuss changing the recommendations. He then fired the current roster of ACIP members in June — in what he described as a "clean sweep" of the panel — as well as removed the agency officials who oversee the panel's vetting and agenda. In a viewpoint published Monday in the Journal of the American Medical Association, the 17 members of the panel fired by Kennedy denounced the health secretary for "dismantling the process by which vaccines have been recommended." "As former ACIP members, we are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of US immunization policy, impact people's access to lifesaving vaccines, and ultimately put US families at risk of dangerous and preventable illnesses," they wrote. Kennedy later replaced the panel with a list of picks that included several allies of the health secretary and opponents of recommendations for COVID-19 and some other vaccines. The committee's new membership is set to meet next week to vote on updated vaccine recommendations for COVID-19 and RSV, among other diseases.
